A Novel Method for Floxed Gene Manipulation Using TAT-Cre Recombinase in Ex Vivo Precision-Cut Lung Slices (PCLS).

Ex vivo model Floxed allele modification Gene activation Gene deletion Gene modification PCLS Permanent gene manipulation Precision-cut lung slices TAT-Cre recombinase TReATS

Journal

Bio-protocol
ISSN: 2331-8325
Titre abrégé: Bio Protoc
Pays: United States
ID NLM: 101635102

Informations de publication

Date de publication:
20 Apr 2024
Historique:
received: 24 01 2024
revised: 18 03 2024
accepted: 22 03 2024
medline: 30 4 2024
pubmed: 30 4 2024
entrez: 30 4 2024
Statut: epublish

Résumé

Precision-cut lung slices (PCLS), ex vivo 3D lung tissue models, have been widely used for various applications in lung research. PCLS serve as an excellent intermediary between in vitro and in vivo models because they retain all resident cell types within their natural niche while preserving the extracellular matrix environment. This protocol describes the TReATS (TAT-Cre recombinase-mediated floxed allele modification in tissue slices) method that enables rapid and efficient gene modification in PCLS derived from adult floxed animals. Here, we present detailed protocols for the TReATS method, consisting of two simple steps: PCLS generation and incubation in a TAT-Cre recombinase solution. Subsequent validation of gene modification involves live staining and imaging of PCLS, quantitative real-time PCR, and cell viability assessment. This four-day protocol eliminates the need for complex Cre-breeding, circumvents issues with premature lethality related to gene mutation, and significantly reduces the use of animals. The TReATS method offers a simple and reproducible solution for gene modification in complex ex vivo tissue-based models, accelerating the study of gene function, disease mechanisms, and the discovery of drug targets. Key features • Achieve permanent ex vivo gene modifications in complex tissue-based models within four days. • Highly adaptable gene modification method that can be applied to induce gene deletion or activation. • Allows simple Cre dosage testing in a controlled ex vivo setting with the advantage of using PCLS generated from the same animal as

Identifiants

pubmed: 38686349
doi: 10.21769/BioProtoc.4980
pii: e4980
pmc: PMC11056012
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e4980

Informations de copyright

©Copyright : © 2024 The Authors; This is an open access article under the CC BY license.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare no competing or financial interests.

Références

Am J Physiol Lung Cell Mol Physiol. 2017 Jun 1;312(6):L896-L902
pubmed: 28314802
Nat Commun. 2019 Mar 12;10(1):1178
pubmed: 30862802
J Pathol. 2018 May;245(1):101-113
pubmed: 29443392
Bio Protoc. 2019 Oct 20;9(20):e3403
pubmed: 33654904
Am J Respir Cell Mol Biol. 2020 Jun;62(6):681-691
pubmed: 31991090
Biomaterials. 2021 Jan;267:120480
pubmed: 33157373
Dis Model Mech. 2023 Nov 1;16(11):
pubmed: 37828896

Auteurs

Sek-Shir Cheong (SS)

National Heart and Lung Institute (NHLI), Imperial College London, London, UK.

Tiago C Luis (TC)

Centre for Inflammatory Diseases, Department of Immunology and Inflammation, Imperial College London, London, UK.

Matthew Hind (M)

National Heart and Lung Institute (NHLI), Imperial College London, London, UK.
National Institute for Health Research (NIHR) Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust, London, UK.

Charlotte H Dean (CH)

National Heart and Lung Institute (NHLI), Imperial College London, London, UK.

Classifications MeSH